CLINICAL_TRIALS
trial_result
· 2019-08-07
Clinical Trial Update: Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients [Phase 2]
Summary
Phase 2 trial update on QCC374 in pulmonary arterial hypertension (terminated; results posted).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2019-08-07